Biosig Technologies, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Streamex Corp. (formerly BioSig Technologies, Inc.) completed a strategic pivot to tokenized asset finance in 2025, reporting a significant net loss driven by non-cash derivative liabilities, while strengthening its liquidity post-year-end.
BioSig Technologies reports its annual results on Form 10-K, highlighting ongoing efforts to regain Nasdaq compliance amidst financial challenges and a potential delisting.
10-K: BioSig Technologies Faces Delisting from Nasdaq Amidst Financial Struggles and Management Turmoil
BioSig Technologies is facing potential delisting from the Nasdaq Capital Market due to non-compliance with listing rules, workforce reductions, and resignations of key personnel.